1. Home
  2. ARDX vs APOG Comparison

ARDX vs APOG Comparison

Compare ARDX & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

SELL

Current Price

$3.24

Market Cap

862.3M

Sector

Health Care

ML Signal

SELL

Logo Apogee Enterprises Inc.

APOG

Apogee Enterprises Inc.

SELL

Current Price

$40.99

Market Cap

794.2M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARDX
APOG
Founded
2007
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
862.3M
794.2M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ARDX
APOG
Price
$3.24
$40.99
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$12.90
★ $45.50
AVG Volume (30 Days)
★ 4.1M
323.9K
Earning Date
10-29-2026
10-06-2026
Dividend Yield
N/A
★ 2.66%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.61
Revenue
$2,607,000.00
★ $1,404,733,000.00
Revenue This Year
$19.98
$5.63
Revenue Next Year
$27.70
$6.57
P/E Ratio
★ N/A
$25.26
Revenue Growth
N/A
★ 3.21
52 Week Low
$3.18
$30.75
52 Week High
$8.40
$50.88

Technical Indicators

Market Signals
Indicator
ARDX
APOG
Relative Strength Index (RSI) 29.24 64.07
Support Level N/A $36.96
Resistance Level $3.63 $41.11
Average True Range (ATR) 0.11 1.57
MACD 0.01 0.70
Stochastic Oscillator 12.50 77.59

Price Performance

Historical Comparison
ARDX
APOG

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.

Share on Social Networks: